⌘K
Loading ticker…
As of 2026-08-24, IDEAYA Biosciences, Inc. Common Stock (IDYA) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.4%, relative volume 1.06×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
IDYA is held by 26 ETFs as of May 2026. Top owner: VTWO at 0.07% weight, $13M notional. Top 3 carry $32M.
Held by 64 ETFs · $388M across latest filings · largest weight 2.71% (IDNA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.07% | $13M | −0.01 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $12M | −0.01 pp |
| VHTVanguard Health Care ETF | 0.04% | $7M | — |
| AVSC | 0.20% | $5M | −0.05 pp |
| CANC | 2.27% | $4M | +0.48 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 1.65% |
| $3M |
| −0.17 pp |
| VTWV | 0.15% | $2M | −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| ILDR | 0.44% | $1M | −0.17 pp |
| ESML | 0.05% | $1M | — |
Showing 10 of 26 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDYA Jan avg: 0.98% median: -5.76% win: 25% σ: 14.26% n: 4 2022-04-12 → 2026-07-31 | IDYA Feb avg: -2.29% median: 1.36% win: 75% σ: 8.95% n: 4 2022-04-12 → 2026-07-31 | IDYA Mar avg: -10.23% median: -11.10% win: 25% σ: 12.97% n: 4 2022-04-12 → 2026-07-31 | IDYA Apr avg: 4.96% median: -7.36% win: 40% σ: 21.37% n: 5 2022-04-12 → 2026-07-31 | IDYA May avg: 6.27% median: 1.27% win: 60% σ: 14.16% n: 5 2022-04-12 → 2026-07-31 | IDYA Jun avg: 10.97% median: 5.68% win: 80% σ: 13.41% n: 5 2022-04-12 → 2026-07-31 | IDYA Jul avg: 7.39% median: 8.12% win: 60% σ: 12.26% n: 5 2022-04-12 → 2026-07-31 | IDYA Aug avg: -2.56% median: -3.71% win: 50% σ: 27.00% n: 4 2022-04-12 → 2026-07-31 (current) | IDYA Sep avg: 8.68% median: 1.36% win: 50% σ: 31.39% n: 4 2022-04-12 → 2026-07-31 | IDYA Oct avg: 4.96% median: 6.95% win: 75% σ: 12.81% n: 4 2022-04-12 → 2026-07-31 | IDYA Nov avg: 7.65% median: 8.83% win: 75% σ: 8.07% n: 4 2022-04-12 → 2026-07-31 | IDYA Dec avg: 1.44% median: -0.66% win: 50% σ: 8.41% n: 4 2022-04-12 → 2026-07-31 |